Vericel (VCEL) director sells 7,000 shares at $38.59

Vericel (VCEL) reported an insider transaction by a director on 11/10/2025.

Rhea-AI Filing Summary

Vericel (VCEL) reported an insider transaction by a director on 11/10/2025. The director exercised 7,000 stock options at an exercise price of $2.63 (code M) and sold 7,000 shares at an average price of $38.59 (code S) under a Rule 10b5-1 trading plan adopted on March 11, 2024.

Following these transactions, the director reported 15,100 shares beneficially owned directly and 10,500 options remaining beneficially owned. The options exercised were part of a grant from May 3, 2017 that vested in equal monthly installments over one year contingent on continued service.

Insider Trade Summary

Exercise and Sale: 7,000 shares ($252K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider MCLAUGHLIN KEVIN F

Role Director

Sold 7,000 shs ($270K)

Approx. gross sale proceeds $270K

Approx. exercise cost $18K

Approx. pre-tax spread $252K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	7,000	$0.00	$0.00
Exercise	Common Stock	7,000	$2.63	$18K
Sale	Common Stock	7,000	$38.59	$270K

Holdings After Transaction: Stock Option (Right to Buy) — 10,500 contracts (Direct); Common Stock — 15,100 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
2. F2. These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VCEL disclose?

A director exercised 7,000 options at $2.63 and sold 7,000 shares at $38.59 on 11/10/2025.

Was the VCEL insider sale under a 10b5-1 plan?

Yes. The sales were made under a Rule 10b5-1 trading plan adopted on March 11, 2024.

How many VCEL shares did the insider hold after the trade?

The director reported 15,100 shares directly owned after the transactions.

What derivative holdings remain after the VCEL transactions?

The filing shows 10,500 derivative securities (stock options) beneficially owned after the reported transactions.

What were the source and terms of the exercised options?

Options were originally granted on May 3, 2017 for up to 17,500 shares, vesting monthly over one year, contingent on continued service.

What transaction codes were used in the VCEL Form 4?

Code M for the option exercise and code S for the sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 04:06 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCLAUGHLIN KEVIN F

(Last) (First) (Middle)

C/O VERICEL CORPORATION

64 SIDNEY STREET

(Street)

CAMBRIDGE MA 02139

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		M		7,000	A	$2.63	22,100	D
Common Stock	11/10/2025		S		7,000	D(1)	$38.59	15,100	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.63	11/10/2025		M		7,000		(2)	05/03/2027	Common Stock	7,000	$0	10,500	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.

2. These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

	/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.